4:40 PM ET
8-K
Loan & Debt
AIM ImmunoTech Debt Financing Update with Streeterville Capital, LLC
AIM ImmunoTech entered into exchange agreements with Streeterville Capital to convert approximately $400,000 of an existing November 2025 promissory note into 1,749,434 shares of common stock. The conversion was executed at an average price of approximately $0.228 per share following prior stockholder approval for the debt satisfaction.
- Counterparty
- Streeterville Capital, LLC